doi: 10.1258/jmb.2009.009003.
Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis
Affiliations
- PMID: 19401508
- DOI: 10.1258/jmb.2009.009003
Item in Clipboard
Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis
J Med Biogr.
2009 May.
Abstract
Dr Lazar Remen (1907-74) was the first, in 1932, to describe the beneficial effect of prostigmine on a myasthenia gravis patient. His observation actually preceeded by two years Mary Broadfoot Walker's (1888-1974) paper, which is considered to be the landmark article on this association.
Similar articles
-
Mary Broadfoot Walker (1888-1974).J Neurol. 2007 Sep;254(9):1306-7. doi: 10.1007/s00415-007-0663-z. J Neurol. 2007. PMID: 18000738 No abstract available.
-
Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology.Neurology. 1998 Nov;51(5):1433-9. doi: 10.1212/wnl.51.5.1433. Neurology. 1998. PMID: 9818874
-
"Crisis" in myasthenia gravis: an historical perspective.Muscle Nerve. 2002 Jul;26(1):1-3. doi: 10.1002/mus.10095. Muscle Nerve. 2002. PMID: 12115943 No abstract available.
-
The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.Neuropharmacology. 2021 Jan;182:108303. doi: 10.1016/j.neuropharm.2020.108303. Epub 2020 Sep 9. Neuropharmacology. 2021. PMID: 32918950 Review.
-
The history of the use of intrathecal prostigmine to achieve fertility in men with spinal cord injuries.Spinal Cord Ser Cases. 2019 May 1;5:37. doi: 10.1038/s41394-019-0183-y. eCollection 2019. Spinal Cord Ser Cases. 2019. PMID: 31632698 Free PMC article. Review. No abstract available.
Cited by
-
Myasthenia gravis.Curr Treat Options Neurol. 2010 May;12(3):231-43. doi: 10.1007/s11940-010-0070-0. Curr Treat Options Neurol. 2010. PMID: 20842584
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical
